TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 0 | 1 | 5 | 18 | 11 | 34 | 13 |
| P | %wins | 100 | 100 | 100 | 100 | 50 | 100 | 92 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/18/05 11:23 | 3/16/05 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wallen William C | ME | O | SVP,Chie | P | 16 | 52.37 | 33 | 0 | 43 | 1 | D | 48 | -4 | 7 | 2 | -7 | -6 | -2 | -4 | 0 | 1 | 1 | 6 | 26 | 56 |
2/27/04 12:43 | 2/27/04 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Wallen William C | ME | O | Chief Sc | P | 10 | 50.66 | 33 | 0 | New | 0 | D | 96 | 41 | 23 | 8 | 9 | 0 | 1 | 2 | 0 | 0 | 8 | 29 | -4 | 11 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |